Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer

被引：0
作者：
Yasmin M. Attia
Salama A. Salama
Samia A. Shouman
Cristina Ivan
Abdelrahman M. Elsayed
Paola Amero
Cristian Rodriguez-Aguayo
Gabriel Lopez-Berestein
机构：
[1] Cairo University,Pharmacology and Experimental Therapeutics Unit, Cancer Biology Department, National Cancer Institute
[2] Al-Azhar University,Pharmacology and Toxicology Department, Faculty of Pharmacy
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
[4] The University of Texas MD Anderson Cancer Center,Center for RNA Interference and Non
[5] The University of Texas MD Anderson Cancer Center,Coding RNA
来源：
Pharmacological Reports | 2022年 / 74卷
关键词：
Breast cancer; Cancer stem cells; Tamoxifen; Cyclin-dependent kinase; SOX2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：366 / 378
页数：12
相关论文
共 50 条
  • [21] Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy
    Hao, Mingang
    Weng, Xiaoling
    Wang, Yingying
    Sun, Xueqin
    Yan, Tingting
    Li, Yu
    Hou, Lidan
    Meng, Xiangjun
    Wang, Jianhua
    BIOCHEMICAL PHARMACOLOGY, 2018, 147 : 128 - 140
  • [22] C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
    Li, Wei
    Xu, Ling
    Che, Xiaofang
    Li, Haizhou
    Zhang, Ye
    Song, Na
    Wen, Ti
    Hou, Kezuo
    Yang, Yi
    Zhou, Lu
    Xin, Xing
    Xu, Lu
    Zeng, Xue
    Shi, Sha
    Liu, Yunpeng
    Qu, Xiujuan
    Teng, Yuee
    BMC CANCER, 2018, 18
  • [23] CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition
    McDermott, Martina S. J.
    Sharko, Amanda C.
    Munie, Jessica
    Kassler, Susannah
    Melendez, Theresa
    Lim, Chang-uk
    Broude, Eugenia, V
    CELLS, 2020, 9 (03)
  • [24] Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer
    Li, Yuehua
    Jiang, Baohong
    Zhu, Hongbo
    Qu, Xiaofei
    Zhao, Liqin
    Tan, Yeru
    Jiang, Yiling
    Liao, Mingchu
    Wu, Xiaoping
    TUMOR BIOLOGY, 2017, 39 (06)
  • [25] C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells
    Wei Li
    Ling Xu
    Xiaofang Che
    Haizhou Li
    Ye Zhang
    Na Song
    Ti Wen
    Kezuo Hou
    Yi Yang
    Lu Zhou
    Xing Xin
    Lu Xu
    Xue Zeng
    Sha Shi
    Yunpeng Liu
    Xiujuan Qu
    Yuee Teng
    BMC Cancer, 18
  • [26] CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer
    Shi, Qiangfeng
    Yang, Wang
    Ouyang, Yiye
    Liu, Yujie
    Cai, Zijie
    BREAST CANCER RESEARCH, 2025, 27 (01)
  • [27] Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle
    Zhu, Jintao
    Ye, Lei
    Sun, Shishen
    Yuan, Jie
    Huang, Jianfeng
    Zeng, Zhiqiang
    AGING-US, 2023, 15 (23): : 13738 - 13752
  • [28] Reduced Expression of RBP7 is Associated with Resistance to Tamoxifen In Luminal A Breast Cancer
    Yan, Xiaolu
    Gao, Zhe
    Zhang, Lixia
    Chen, Chuan
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (08) : 929 - 937
  • [29] Linking autophagy with inflammation through IRF1 signaling in ER+ breast cancer
    Cook, Katherine L.
    Schwartz-Roberts, Jessica L.
    Baumann, William T.
    Clarke, Robert
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (01)
  • [30] Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
    Vafeiadou, Vasiliki
    Hany, Dina
    Picard, Didier
    CANCERS, 2022, 14 (04)
12345